Mechanistic description
H3K9me3 Heterochromatin Loss at Pericentromeric Repeats
Mechanism / pathway
- H3K9me3 Heterochromatin
- neurodegeneration
Evidence for (5)
Suv39h-catalyzed H3K9me3 is critical for euchromatic genome organization and the maintenance of gene transcription.
The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells.
HP1 proteins regulate nucleolar structure and function by secluding pericentromeric constitutive heterochromatin.
Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability.
Toxic Y chromosome: Increased repeat expression and age-associated heterochromatin loss in male Drosophila with a young Y chromosome.
Evidence against (2)
Heterochromatin relaxation is a broad aging and disease concept, but review-level evidence does not establish H3K9me3 pericentromeric loss as a specific neurodegenerative mechanism.
Therapeutic work around H3K9 methyltransferase G9a is mainly framed for neuropsychiatric disorders, so extension to neurodegeneration remains indirect.
Evidence matrix
Supporting
- Suv39h-catalyzed H3K9me3 is critical for euchromatic genome organization and the maintenance of gene transcription. PMID:38719473 · 2024 · Genome Res
- The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells. PMID:27125671 · 2016 · Genes Dev
- HP1 proteins regulate nucleolar structure and function by secluding pericentromeric constitutive heterochromatin. PMID:36533441 · 2023 · Nucleic Acids Res
- Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability. PMID:22081068 · 2012 · Oncogene
- Toxic Y chromosome: Increased repeat expression and age-associated heterochromatin loss in male Drosophila with a young Y chromosome. PMID:33886541 · 2021 · PLoS Genet
Contradicting
- Heterochromatin relaxation is a broad aging and disease concept, but review-level evidence does not establish H3K9me3 pericentromeric loss as a specific neurodegenerative mechanism. PMID:34626428 · 2021 · Cells
- Therapeutic work around H3K9 methyltransferase G9a is mainly framed for neuropsychiatric disorders, so extension to neurodegeneration remains indirect. PMID:40384397 · 2025 · Med Res Rev
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). H3K9me3 Heterochromatin Loss at Pericentromeric Repeats. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-96795760
@misc{scidex_hypothesis_h9679576,
title = {H3K9me3 Heterochromatin Loss at Pericentromeric Repeats},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-96795760},
note = {SciDEX artifact hypothesis:h-96795760}
}